中财网 中财网股票行情
金城医药(300233)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)93169.66353831.25256875.27170529.3382952.65
营业收入(万元)93169.66353831.25256875.27170529.3382952.65
营业总成本(万元)82239.16329366.78238674.95157895.4876665.37
营业成本(万元)51710.40199112.71148123.7496972.1047542.33
净利润(万元)8297.1317641.4613953.7010876.615566.59
归属于母公司的净利润(万元)8297.1317470.9413248.0410170.945015.47
营业利润(万元)11564.9622584.9217551.6313417.426874.76
利润总额(万元)11555.4822540.7517630.1413569.247023.67
少数股东损益(万元)618.761860.161417.47906.31472.50
基本每股收益(元)0.22(元)0.45(元)0.34(元)0.26(元)0.13(元)
稀释每股收益(元)0.22(元)0.45(元)0.34(元)0.26(元)0.13(元)
非经常性损益(万元)265.78----929.69724.98
扣除非经常性损益后净利润(万元)8031.3615818.2711938.479241.254290.49
总资产(万元)590050.38591607.93594532.04583724.80588721.94
总负债(万元)208156.97213501.99220254.94210520.61215923.72
归属于母公司股东权益合计(万元)374461.66371413.36368027.16367408.34367127.26
股东权益合计(万元)381893.40378105.94374277.10373204.18372798.22
实收资本(股本)(万元)38387.4638387.4638592.4438592.4438741.10
资本公积(万元)232769.78232769.78235865.23238548.77240259.12
未分配利润(万元)92121.9283824.7880990.3877841.9578475.63
经营活动产生的现金流量净额(万元)4137.3266407.5146092.1028138.372670.33
经营活动现金流入小计(万元)90876.22333070.95240749.42162947.4577215.53
经营活动现金流出小计(万元)86738.90266663.44194657.31134809.0774545.19
投资活动产生的现金流量净额(万元)-5141.51-30998.88-15736.66-12932.69-7326.90
投资活动现金流入小计(万元)9669.4118714.8219002.168108.924692.49
投资活动现金流出小计(万元)14810.9249713.6934738.8221041.6112019.39
筹资活动产生的现金流量净额(万元)2575.13-24331.08-9333.90-9276.888298.44
筹资活动现金流入小计(万元)19000.0034836.8332856.2121666.2119956.82
筹资活动现金流出小计(万元)16424.8759167.9242190.1030943.0911658.38
期末现金及现金等价物余额(万元)92100.1290402.11100249.7885040.9382541.54
最后修改日期2024-04-252024-03-282023-10-242023-08-212023-04-26
↑返回页顶↑

转至金城医药（300233）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。